Transfuse Omidubicel in Periph Vein, Perc, New Tech 8

This code describes the intravenous administration of omidubicel, a novel stem cell therapy, directly into a peripheral vein. Omidubicel is an expanded cord blood product designed to accelerate neutrophil and platelet engraftment following myeloablative conditioning.

This code is used when a patient receives omidubicel via a percutaneous peripheral intravenous line, typically as part of a hematopoietic stem cell transplant regimen. It is specifically indicated for adult and pediatric patients with hematologic malignancies undergoing myeloablative conditioning.

• Ensure documentation clearly specifies omidubicel as the transfused substance.
• Verify the approach was percutaneous into a peripheral vein; central venous access would necessitate a different approach value.
• This code is for the transfusion itself, not the preparation or procurement of the omidubicel.